Lymphoma Research: 10 LLS Grants You Should Know

0
(0)

news_14_Artboard 343 copy 183

Research is determinant for advancing the medical field and lymphoma is no exception. The Leukemia and Lymphoma Society (LLS) is one of the major organizations focused on providing support to investigators to continue increasing understanding about the disease as well as improving its diagnosis and treatment. In order to do so, LLS attributes academic grants to support basic and translational leukemia, lymphoma and myeloma research. These are ten examples of LLS academic grants.

1. Career Development Program

The career development program is meant for highly qualified investigators who demonstrated capacities for independent, sustained and original investigation in the field of hematologic malignancies. These grants are awarded at different stages of research careers in specific categories. To be eligible, investigators need to hold an independent faculty-level or equivalent position and holding substantial support for the research from a national agency. The grant is worth $110,000 per year for five years and applications will open soon.

Find out  more here.

2. Specialized Center of Research Program

“The SCOR program intends to bring together distinguished investigators from one or several institutions to develop a focused research center, foster new interactions and cooperation, and enhance interdisciplinary research among the participants to understand the causes of various hematological malignancies and ultimately develop effective treatments for cancer patients,” state the LLS. “The SCOR application process is opening soon.”

Know more here.

Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência. Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.
×
Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência. Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.
Latest Posts
  • ATG-019 Phase 1 trial
  • ME-401, FDA fast track
  • Tafasitamab combo, lymphoma
  • blood biomarkers

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Leave a Comment

Your email address will not be published. Required fields are marked *